zalasta 5mg orodispersible tablets
consilient health ltd - olanzapine - orodispersible tablet - 5mg
zalasta 10mg orodispersible tablets
consilient health ltd - olanzapine - orodispersible tablet - 10mg
zalasta 15mg orodispersible tablets
consilient health ltd - olanzapine - orodispersible tablet - 15mg
zalasta 20mg orodispersible tablets
consilient health ltd - olanzapine - orodispersible tablet - 20mg
olanzapine 10mg tablets
mylan - olanzapine - tablet - 10mg
olanzapine 20mg tablets
mylan - olanzapine - tablet - 20mg
zalasta tablets
krka polska sp. z o.o. - olanzapine - tablets - 5mg
zalasta tablets
krka polska sp. z o.o. - olanzapine - tablets - 10mg
zyprexa 5 mg
eli lilly israel ltd, israel - olanzapine - tablets - olanzapine 5 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. zyprexa is indicated for the management of the manifestations of psychotic disorders. zyprexa is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment zyprexa is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of zyprexa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.
zyprexa 7.5 mg
eli lilly israel ltd, israel - olanzapine - tablets - olanzapine 7.5 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. zyprexa is indicated for the management of the manifestations of psychotic disorders. zyprexa is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment zyprexa is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of zyprexa with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.